FDA Black Box Warning Removed โ€” Feb 2026

Bio-Identical Hormone
Replacement Therapy

The science has evolved. The FDA has acted. And with estradiol patches on nationwide backorder, custom compounded BHRT offers the personalized solution you've been looking for.

6,000
Women reach menopause daily
86%
Increase in HRT Rx since 2021
< 5%
Of eligible women using HRT
2026
Estradiol patch shortage ongoing

Why Bio-Identical Hormones? Why Now?

For over two decades, fear from a single study kept millions of women from life-changing therapy. The evidence has caught up โ€” and the FDA has responded.

๐Ÿงฌ

Bioidentical โ‰  Synthetic

Bio-identical hormones are molecularly identical to what your body produces. The WHI studied synthetic hormones โ€” not the same thing.

๐Ÿ’Š

Route Matters

Transdermal estradiol (creams, gels) bypasses the liver, avoiding the blood clot and stroke risks associated with oral estrogen.

โฑ๏ธ

Timing Is Key

Starting within 10 years of menopause provides cardiovascular protection, bone preservation, and cognitive benefits.

โš•๏ธ

Personalized Care

Compounding means your therapy is tailored to your exact needs โ€” not limited to one-size-fits-all commercial products.

โš ๏ธ

Estradiol Patch Shortage โ€” You Have Options

All major estradiol patches โ€” Climara, Vivelle-Dot, Dotti, and generics โ€” are on nationwide backorder through 2026. The shortage is driven by surging demand after the FDA's removal of the black box warning. Medicine Center Pharmacy compounds custom transdermal estradiol creams and gels that deliver the same bio-identical hormone through your skin. Your prescriber can call us at 330.339.4466 to discuss transitioning your therapy.

Compounded BHRT Treatment Options

Every woman's hormonal needs are unique. We compound personalized formulations in the exact dose, strength, and delivery form your prescriber specifies.

Eโ‚‚

Estradiol (E2)

The most potent form of estrogen โ€” molecularly identical to what your ovaries produce. Transdermal delivery does not increase VTE or stroke risk, improves endothelial function, and provides neuroprotection.

Compounded forms: Topical creams & gels, sublingual troches, vaginal creams, custom-dose capsules

28 RCTs confirm E2 reduces fracture risk more than CEE
Pโ‚„

Micronized Progesterone (P4)

Identical to progesterone your corpus luteum produces โ€” NOT the same as synthetic MPA. Supports sleep, mood, bone health, and cardiovascular function. Does not increase breast cancer risk.

Compounded forms: Oral capsules (IR & SR), sublingual troches, topical creams, vaginal suppositories

E3N study: P4 + transdermal E2 = no increased VTE risk
T

Testosterone โ€” For Women, Too

Declining testosterone contributes to low libido, fatigue, brain fog, and reduced muscle mass. No FDA-approved product exists for women โ€” compounding provides appropriate female dosing.

Compounded forms: Topical creams & gels (low-dose), sublingual troches, injectable preparations

10-year cohort: reduced invasive breast cancer incidence with T therapy

The Evidence: Bioidentical vs. Synthetic

The WHI studied synthetic hormones in older women. Post-WHI research consistently shows that bio-identical hormones โ€” especially delivered transdermally โ€” offer a fundamentally different safety profile.

Outcome Synthetic (CEE + MPA) Bioidentical (E2 + P4)
VTE / Blood Clots โ†‘ 111% increase (oral CEE + MPA) No increase with transdermal E2 (RR 0.94)
Stroke Risk โ†‘ 41% increase (oral CEE + MPA) No increase with transdermal E2 + P4
Breast Cancer โ†‘ 26% increase (MPA is the driver) P4 shows no proliferative effect; may be protective
Cardiovascular โ†‘ 29% CHD events (CEE + MPA arm) Cardioprotective when started within 10 years
HDL Cholesterol Improved, but MPA partially offsets benefit E + P4 preserves full HDL-C benefit (PEPI)
Cognition / Dementia CEE + MPA: HR 0.93 (non-significant) CEE alone: HR 0.74 for AD/dementia mortality; E2 > CEE
Bone / Fractures โ†“ 34% hip fracture reduction โ†“ 39% hip fracture; E2 > CEE in meta-analysis

Sources: Rossouw (2002), Anderson (2004), Manson (2017), Vinogradova (2019), Foschi (2025), Cho (2023), PEPI Trial (1995). Full references available in downloadable guides.

Why Custom Compounding?

Commercial hormone products come in limited, fixed doses. Compounding gives your prescriber complete control.

๐ŸŽฏ

Personalized Dosing

Exact dose based on your symptoms and lab results โ€” not what's commercially available.

๐Ÿ”„

Multiple Forms

Creams, gels, troches, capsules, vaginal preparations โ€” choose what works for you.

๐Ÿงช

Combination Formulas

E2 + P4 + T in a single application for convenience and compliance.

โšก

Quick Adjustments

As needs change, we adjust your formulation โ€” often within 24โ€“48 hours.

Get Started

Whether you're a patient exploring your options or a prescriber looking for compounding solutions, we're here to help.

Download Your Free BHRT Patient Guide

Our comprehensive guide covers everything you need to know about bio-identical hormone therapy โ€” the science, your options, and how to get started.

  • What the WHI study really showed
  • Bioidentical vs. synthetic hormones
  • Why route of administration matters
  • Treatment options: E2, P4, Testosterone
  • The estradiol patch shortage โ€” your alternatives
  • Next steps to discuss with your provider

Prescriber Clinical Reference & Consultation

Access our evidence-based BHRT prescriber reference with dosing tables, monitoring parameters, and compounding specifications.

  • WHI limitations & post-WHI evidence summary
  • VTE, CV, and cancer risk data by formulation
  • Compounded dosing guidelines (E2, P4, T)
  • Complete monitoring parameter table
  • Patient risk stratification framework
  • Estradiol patch dose-conversion guidance

Prefer to call? Ask for Janice Marciniak, R.Ph. (HRT Specialist) or Brad White, R.Ph. at 330.339.4466.